Dave’s career at P&G spans over 20 years and includes experience across health care categories, addressing a variety of focus areas (gastrointestinal, respiratory, neuropathy, pain, immunosuppression, musculoskeletal, and vitamins, minerals, and supplements). His familiarity with global regulatory health agencies and his knowledge of the key pathways for product development and substantiation have paved the way for new innovations across the company.
WHAT INNOVATION AT P&G MEANS TO DAVE:
“The consistent pursuit of deep consumer understanding informs the biggest challenges, so we can develop new and meaningful solutions, improving the lives of consumers around the world. For example, just a few years ago, consumers had no over-the-counter options for their nerve pain, and today, our nerve care team is working to bring solutions to consumers around the world, working across multiple regulatory classifications.”
INNOVATION HIGHLIGHTS:Received New Product IRI 2019 Pacesetter Award for DayQuil and Nyquil VapoCool.
Brought the technology of Neurobion, the world’s leader in nerve care with over 50 years of expertise and experience to the US with Nervive. These leading nerve care brands support nerve health and provide a solution for occasional discomfort, aches and weakness associated with aging.
Supported the launch of Align in the United States: it is now the #1 Doctor and Gastroenterologist recommended probiotic brand.
